This year’s 21st UK DAWN AC User Group Meeting was a great success with a varied programme of talks and lots of opportunity for networking and discussing best practice with colleagues from around the country. A big thank you to all of the speakers and delegates who travelled to the Lake District for the event, making it such a success.

Slideshows of the presentations are available to view on the DAWN AC User Group Presentations page and the User Group Proceedings document will be available soon, providing a summary of all of the talks given:

A New Induction Process – Anne-Marie Etherington, Lead Nurse Practitioner, Glasgow & Clyde Anticoagulation Service

A Review of Self-Testing Patients – How Are They Doing? – Jeff Walker, Chief Biomedical Scientist, Mid Yorkshire Hospitals NHS Trust

Using the Variability of INRs to Indicate the Risk of an Event in DAWN AC – Variance Growth Rate – Syd Stewart, 4S DAWN Clinical Software

Higher Than 8 In-Clinic INRs and How We Manage Them – Sean O’Brien, Biomedical Scientist, Blackpool & Fylde NHS Trust

DAWN AC Product Update – Brenda Nicol, 4S DAWN Clinical Software

Staff Competency & Protocols – Wendy Cottee, Lead Biomedical Scientist, Worthing & Southlands NHS Trust

An Audit of NOAC Patients Taken Off Warfarin – Sue Bacon, Anticoagulation Nurse Specialist, Bristol NHS Trust

Dabigatran & Rivaroxaban Modules for DAWN AC – George Kitching, 4S DAWN Clinical Software

Leicester’s New DVT Module – Jane Strong, Consultant Haematologist, Jo Eggleston & Victoria Frimpong, DVT Specialist Nurses, University Hospital of Leicester

Overcoming Communication Problems in the Anticoagulation Service at CHFT – Harry Crank, Senior MLA, Calderdale & Huddersfield NHS Foundation Trust

Using DAWN AC for Paediatric Patients Managed on Warfarin – Jenny Brown, Paediatric Pharmacist, Leeds Children’s Hospital

Systematic Anticoagulation Management in the Rural Health Setting – Lisa Vaughn, Clinical Manager, Confluence Health Anticoagulation Service, USA (via teleconference)